Cargando…

A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]

BACKGROUND: Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT deman...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilburn, Olivia, Wilburn, Paul, Rockson, Stanley G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440867/
https://www.ncbi.nlm.nih.gov/pubmed/16571129
http://dx.doi.org/10.1186/1471-2407-6-84
_version_ 1782127337669656576
author Wilburn, Olivia
Wilburn, Paul
Rockson, Stanley G
author_facet Wilburn, Olivia
Wilburn, Paul
Rockson, Stanley G
author_sort Wilburn, Olivia
collection PubMed
description BACKGROUND: Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT demands substantial time and effort from patients to maintain these benefits; the treatments are not always well-accepted, and patients may suffer from a deterioration in quality-of-life or a time-dependent loss of initial treatment benefits. A new device designed for home use by the patient, the Flexitouch™, has been developed to mechanically simulate MLD. We have undertaken a prospective, randomized, crossover study of the efficacy of the Flexitouch™, when compared to massage, in the self-administered maintenance therapy of lymphedema. METHODS: A prospective, randomized, crossover study of maintenance therapy was performed in 10 patients with unilateral breast cancer-associated lymphedema of the arm. Each observation phase included self-administered treatment with the Flexitouch™ or massage, 1 hour daily for 14 days, respectively, followed by crossover to the alternate treatment phase. Each treatment phase was preceded by a 1 week treatment washout, with use of garment only. The sequence of treatment was randomly assigned. The potential impact of treatment modality on quality of life was assessed with serial administration of the SF-36. RESULTS: Statistical analysis disclosed that the order of treatment had no outcome influence, permitting 10 comparisons within each treatment group. Post-treatment arm volume reduced significantly after the Flexitouch™, but not after self-administered massage. The patients' mean weight decreased significantly with Flexitouch™ use, but not with massage. The Flexitouch™ device was apparently well-tolerated and accepted by patients. Serial SF-36 administration showed no deterioration in physical or psychosocial scores compared to baseline measurements; there were no statistical differences in scores when the two treatment modalities were compared. CONCLUSION: This short-term prospective evaluation of the Flexitouch™ suggests that the device may provide better maintenance edema control than self-adiminstered massage in breast cancer-associated lymphedema. The apparent ease of use and reliability of response to the device suggest that further broad-scale testing is warranted.
format Text
id pubmed-1440867
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14408672006-04-20 A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412] Wilburn, Olivia Wilburn, Paul Rockson, Stanley G BMC Cancer Research Article BACKGROUND: Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT demands substantial time and effort from patients to maintain these benefits; the treatments are not always well-accepted, and patients may suffer from a deterioration in quality-of-life or a time-dependent loss of initial treatment benefits. A new device designed for home use by the patient, the Flexitouch™, has been developed to mechanically simulate MLD. We have undertaken a prospective, randomized, crossover study of the efficacy of the Flexitouch™, when compared to massage, in the self-administered maintenance therapy of lymphedema. METHODS: A prospective, randomized, crossover study of maintenance therapy was performed in 10 patients with unilateral breast cancer-associated lymphedema of the arm. Each observation phase included self-administered treatment with the Flexitouch™ or massage, 1 hour daily for 14 days, respectively, followed by crossover to the alternate treatment phase. Each treatment phase was preceded by a 1 week treatment washout, with use of garment only. The sequence of treatment was randomly assigned. The potential impact of treatment modality on quality of life was assessed with serial administration of the SF-36. RESULTS: Statistical analysis disclosed that the order of treatment had no outcome influence, permitting 10 comparisons within each treatment group. Post-treatment arm volume reduced significantly after the Flexitouch™, but not after self-administered massage. The patients' mean weight decreased significantly with Flexitouch™ use, but not with massage. The Flexitouch™ device was apparently well-tolerated and accepted by patients. Serial SF-36 administration showed no deterioration in physical or psychosocial scores compared to baseline measurements; there were no statistical differences in scores when the two treatment modalities were compared. CONCLUSION: This short-term prospective evaluation of the Flexitouch™ suggests that the device may provide better maintenance edema control than self-adiminstered massage in breast cancer-associated lymphedema. The apparent ease of use and reliability of response to the device suggest that further broad-scale testing is warranted. BioMed Central 2006-03-29 /pmc/articles/PMC1440867/ /pubmed/16571129 http://dx.doi.org/10.1186/1471-2407-6-84 Text en Copyright © 2006 Wilburn et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Wilburn, Olivia
Wilburn, Paul
Rockson, Stanley G
A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title_full A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title_fullStr A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title_full_unstemmed A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title_short A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]
title_sort pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [isrctn76522412]
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440867/
https://www.ncbi.nlm.nih.gov/pubmed/16571129
http://dx.doi.org/10.1186/1471-2407-6-84
work_keys_str_mv AT wilburnolivia apilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412
AT wilburnpaul apilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412
AT rocksonstanleyg apilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412
AT wilburnolivia pilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412
AT wilburnpaul pilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412
AT rocksonstanleyg pilotprospectiveevaluationofanovelalternativeformaintenancetherapyofbreastcancerassociatedlymphedemaisrctn76522412